Free tool
Drugs in development
Last checked: Nov 20, 2026Latest source record: rebuilt Nov 18, 2026Source: ClinicalTrials.govMethods & limitations
Drugs in development
3,685
Not FDA-approved
In Phase 3
1,424
Highest phase reached
Matching your filters
278
278 drugs in development
Names, sponsors and conditions come from the trial records. Click a drug for its trials.
- ICP-488Phase 33 trials
Beijing InnoCare Pharma Tech Co., Ltd. · Plaque Psoriasis Patients, Primary Sjögren's Syndrome, Cutaneous Lupus Erythematosus (CLE)
- LNK01001Phase 33 trials
Lynk Pharmaceuticals Co., Ltd · Ankylosing Spondylitis, Atopic Dermatitis, Rheumatoid Arthritis
- PP405 0.05%PP405Phase 33 trials
Pelage Pharmaceuticals, Inc. · Androgenetic Alopecia
- QY201Phase 33 trials
E-nitiate Biopharmaceuticals (Hangzhou) Co., Ltd. · Adult Subjects With Non-Segmental Vitiligo, Atopic Dermatitis (AD), Adolescent Participants With Moderate to Severe Atopic Dermatitis (AD)
Beijing VDJBio Co., LTD. · Anti IL-6R, Idiopathic Multicentric Castleman's Disease, Castleman's Disease, Multicentric
- RocatinlimabAMG 451Phase 33 trials
Amgen · Atopic Dermatitis
- SG301Phase 33 trials
Hangzhou Sumgen Biotech Co., Ltd. · Systemic Lupus Erythematosus (SLE), Relapsed/Refractory Multiple Myeloma, Antibody Mediated Rejection
- SHR-1314Phase 33 trials
Suzhou Suncadia Biopharmaceuticals Co., Ltd. · Active Non-radiographic Axial Spondyloarthritis, Children and Adolescents Aged 6 to 18 With Moderate-to-Severe Plaque Psoriasis, Psoriatic Arthritis
- TQH2722Phase 33 trials
Shanghai Chia Tai Tianqing Pharmaceutical Technology Development Co., Ltd. · Seasonal Allergic Rhinitis, Atopic Dermatitis
- Zola-celBMS-986353, CC-97540Phase 33 trials
Bristol Myers Squibb · Systemic Sclerosis, Lupus Erythematosus, Systemic, Lupus Nephritis
- ABBV-722Phase 32 trials
AbbVie · Rheumatoid Arthritis, Systemic Sclerosis
- ADSTEM Inj.Phase 32 trials
EHL Bio Co., Ltd. · Atopic Dermatitis
- AfimetoranBMS-986256, BLN-256Phase 32 trials
Beeline Medicines Corporation · Systemic Lupus Erythematosus, Cutaneous Lupus Erythematosus (CLE), Systematic Lupus Erythematosus
- AK111Phase 32 trials
Akeso · Psoriasis, Skin Diseases, Ankylosing Spondylitis
- BDB-001Phase 32 trials
Staidson (Beijing) Biopharmaceuticals Co., Ltd · ANCA Associated Vasculitis (AAV), ANCA-associated Vasculitis
- BFB759Phase 32 trials
Bluefin Biomedicine, Inc. · Atopic Dermatitis (AD), Hidradenitis Suppurativa (HS)
- CMS-D001Phase 32 trials
Dermavon Holdings Limited · Moderate to Severe Plaque Psoriasis, Moderate to Severe Atopic Dermatitis
- DZPCDP7657, Dapirolizumab pegolPhase 32 trials
UCB · Systemic Lupus Erythematosus
- HS-20137QX004NPhase 32 trials
Hansoh BioMedical R&D Company · Moderate-to-severe Plaque Psoriasis
- IBI112Phase 32 trials
Innovent Biopharmaceutical Technology (Hangzhou) Co., LTD. · Psoriasis
- MH004Phase 32 trials
Minghui Pharmaceutical (Hangzhou) Ltd · Vitiligo, Atopic Dermatitis (AD)
- NetakimabPhase 32 trials
Biocad · Plaque Psoriasis
- PicankibartPhase 32 trials
Innovent Biopharmaceutical Technology (Hangzhou) Co., LTD. · Psoriatic Arthritis, Plaque Psoriasis
- piclidenosonPhase 32 trials
Can-Fite BioPharma · Plaque Psoriasis, Lowe Syndrome
- SHR0302Phase 32 trials
Jiangsu HengRui Medicine Co., Ltd. · Non-segmental Vitiligo, Psoriatic Arthritis
- SoquelitinibCPI-818Phase 32 trials
Corvus Pharmaceuticals, Inc. · Atopic Dermatitis, Atopic Dermatitis Eczema, Eczema
- StapokibatrtPhase 32 trials
Keymed Biosciences Co.Ltd · Atopic Dermatitis
- SYHX1901Phase 32 trials
CSPC Ouyi Pharmaceutical Co., Ltd. · Moderate to Severe Plaque Psoriasis, Severe Alopecia Areata
- TEV-53408Phase 32 trials
Teva · Vitiligo, Celiac Disease
- TILDPhase 32 trials
Sun Pharmaceutical Industries Limited · Active Psoriatic Arthritis
- VC005 groupPhase 32 trials
Jiangsu vcare pharmaceutical technology co., LTD · Atopic Dermatitis, Moderate to Severe Atopic Dermatitis
- WD-890Phase 32 trials
Zhejiang Wenda Pharma Technology LTD. · Brief Description of Focus of Study, Moderate to Severe Plaque Psoriasis
- Blinded EnvudeucitinibPhase 31 trial
Alumis Inc · Plaque Psoriasis, Psoriasis (PsO), Psoriasis
- CMAB015Phase 31 trial
Taizhou Mabtech Pharmaceutical Co.,Ltd · Psoriasis
- CTP-543Phase 31 trial
Sun Pharmaceutical Industries, Inc. · Alopecia Areata
- DA-001Phase 31 trial
Applied Biology, Inc. · Telogen Effluvium, Female Pattern Hair Loss, Female Pattern Hair Loss, Androgenic Alopecia
- DA-007Phase 31 trial
Applied Biology, Inc. · Chemotherapy Induced Alopecia, Chemotherapy Side Effects
- GNR-068Phase 31 trial
AO GENERIUM · Plaque Psoriasis
- GS101Phase 31 trial
Jiangsu Genscend Biopharmaceutical Co., Ltd · Atopic Dermatitis (AD)
- HPP737Phase 31 trial
Newsoara Biopharma Co., Ltd. · Psoriasis
- IBI3027Phase 31 trial
Innovent Biologics (Suzhou) Co. Ltd. · Atopic Dermatitis
- LevilimabPhase 31 trial
Biocad · Rheumatoid Arthritis
- LW402Phase 31 trial
Shanghai Longwood Biopharmaceuticals Co., Ltd. · Moderate to Severe Atopic Dermatitis
- LZM012Phase 31 trial
Livzon Pharmaceutical Group Inc. · Psoriasis
- N1087Phase 31 trial
Eurofarma Laboratorios S.A. · Female Pattern Hair Loss, Female Pattern Hair Loss, Androgenic Alopecia
- Open-Label EnvudeucitinibPhase 31 trial
Alumis Inc · Plaque Psoriasis, Psoriasis (PsO), Psoriasis
- PG-011GelPG-011Gel 3%Phase 31 trial
Prime Gene Therapeutics Co., Ltd. · Atopic Dermatitis
- proposed biosimilar to etanerceptMB04Phase 31 trial
mAbxience Research S.L. · Rheumatoid Arthritis (RA)
- QL2106Phase 31 trial
Qilu Pharmaceutical Co., Ltd. · Plaque Psoriasis
- QL2108Phase 31 trial
Qilu Pharmaceutical Co., Ltd. · Atopic Dermatitis
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.